Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hohl, RJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 41 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Holstein, SA; Hohl, RJ
      Interaction of cytosine arabinoside and lovastatin in human leukemia cells

      LEUKEMIA RESEARCH
    2. Chapel, S; Veng-Pedersen, P; Hohl, RJ; Schmidt, RL; McGuire, EM; Widness, JA
      Changes in erythropoietin pharmacokinetics following busulfan-induced bonemarrow ablation in sheep: Evidence for bone marrow as a major erythropoietin elimination pathway

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    3. Karp, JE; Lancet, JE; Kaufmann, SH; End, DW; Wright, JJ; Bol, K; Horak, I; Tidwell, ML; Liesveld, J; Kottke, TJ; Ange, D; Buddharaju, L; Gojo, I; Highsmith, WE; Belly, RT; Hohl, RJ; Rybak, ME; Thibault, A; Rosenblatt, J
      Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

      BLOOD
    4. Cermak, DM; Wiemer, DF; Lewis, K; Hohl, RJ
      2-(acyloxy)ethylphosphonate analogues of prenyl pyrophosphates: Synthesis and biological characterization

      BIOORGANIC & MEDICINAL CHEMISTRY
    5. Jung, KY; Hohl, RJ; Wiemer, AJ; Wiemer, DF
      Synthesis of phosphonate derivatives of uridine, cytidine, and cytosine arabinoside

      BIOORGANIC & MEDICINAL CHEMISTRY
    6. Yung, WKA; Albright, RE; Olson, J; Fredericks, R; Fink, K; Prados, MD; Brada, M; Spence, A; Hohl, RJ; Shapiro, W; Glantz, M; Greenberg, H; Selker, RG; Vick, NA; Rampling, R; Friedman, H; Phillips, P; Bruner, J; Yue, N; Osoba, D; Zaknoen, S; Levin, VA
      A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

      BRITISH JOURNAL OF CANCER
    7. Burns, CP; Halabi, S; Clamon, GH; Hars, V; Wagner, BA; Hohl, RJ; Lester, E; Kirshner, JJ; Vinciguerra, V; Paskett, E
      Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and leukemia group B study 9473

      CLINICAL CANCER RESEARCH
    8. HOLSTEIN SA; CERMAK DM; WIEMER DF; LEWIS K; HOHL RJ
      PHOSPHONATE AND BISPHOSPHONATE ANALOGS OF FARNESYL PYROPHOSPHATE AS POTENTIAL INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

      Bioorganic & medicinal chemistry
    9. GAO F; HOHL RJ; SHIRES TK
      GERANYLGERANIOL RESTORES CELL-GROWTH AND RAS PROCESSING IN MEVALONATE-DEPLETED FIBROBLAST CELLS

      The FASEB journal
    10. HOHL RJ; SHERBURNE AR; FEELEY JE; HUISMAN THJ; BURNS CP
      LOW PULSE OXIMETER-MEASURED HEMOGLOBIN OXYGEN SATURATIONS WITH HEMOGLOBIN CHEVERLY

      American journal of hematology
    11. HOHL RJ; LEWIS KA; CERMAK DM; WIEMER DF
      STEREOCHEMISTRY-DEPENDENT INHIBITION OF RAS FARNESYLATION BY FARNESYLPHOSPHONIC-ACIDS

      Lipids
    12. HOHL RJ; LEWIS KA; GUSTIN DM
      EFFECTS OF PERILLYL ALCOHOL ON RAS EXPRESSION IN HUMAN BLADDER-CANCERAND MONONUCLEAR BLOOD-CELLS

      Clinical pharmacology and therapeutics
    13. LEWIS KA; HOHL RJ
      MODULATION OF RAS EXPRESSION IN HUMAN-MALIGNANT CELLS BY DIETARY-SUPPLEMENTS

      Nutrition
    14. HOHL RJ; POGATCHNIK DM; LEWISTIBESAR K; WIEMER DF
      DIFFERENTIAL INHIBITION OF FARNESYL-PROTEIN TRANSFERASE AND SQUALENE SYNTHASE BY ISOPRENOID PHOSPHONIC-ACIDS

      Clinical pharmacology and therapeutics
    15. HOHL RJ; LEWISTIBESAR K; POGATCHNIK DM; WIEMER DF
      DIFFERENTIAL-EFFECTS OF ISOPRENOID PHOSPHONIC-ACIDS ON RAS FARNESYLATION AND CHOLESTEROL-SYNTHESIS

      Journal of investigative medicine
    16. THIBAULT A; SAMID D; TOMPKINS AC; FIGG WD; COOPER MR; HOHL RJ; TREPEL J; LIANG B; PATRONAS N; VENZON DJ; REED E; MYERS CE
      PHASE-I STUDY OF LOVASTATIN, AN INHIBITOR OF THE MEVALONATE PATHWAY, IN PATIENTS WITH CANCER

      Clinical cancer research
    17. PETERS C; MILLER J; ABEL SL; MCMILLAN SK; GETCHELL JP; GILLER RH; HOHL RJ; DEALARCON PA
      IOWA NEWBORN HEMOGLOBINOPATHY SCREENING AND COMPREHENSIVE CARE - A MODEL FOR RURAL STATES

      Journal of pediatric hematology/oncology
    18. LEE CK; HARMAN GS; HOHL RJ; GINGRICH RD
      FATAL CYCLOPHOSPHAMIDE CARDIOMYOPATHY - ITS CLINICAL COURSE AND TREATMENT

      Bone marrow transplantation
    19. HOHL RJ; POGATCHNIK DM; LEWISTIBESAR K; WIEMER DF
      INHIBITION OF RAS FARNESYLATION BY ISOPRENOID PHOSPHONIC-ACIDS

      Clinical pharmacology and therapeutics
    20. GOLDMAN F; HOHL RJ; CRABTREE J; LEWISTIBESAR K; KORETZKY G
      LOVASTATIN INHIBITS T-CELL ANTIGEN RECEPTOR SIGNALING INDEPENDENT OF ITS EFFECTS ON RAS

      Blood
    21. LEE CK; GINGRICH RD; HARMAN GS; HOHL RJ; SVSEL IA; FRANCY RJ; AJRAM KA; JOHANNSEN SM
      GRAFT-VERSUS-HOST DISEASE AND SURVIVAL IN GRADED INCREMENTAL ADD-BACK(GIAB) FOR T-CELL DEPLETION-ALLOGENEIC BONE-MARROW TRANSPLANTATION (TCD-AL-BMT), COMPARED TO 2-LEVEL ADD-BACK (TLAB)

      Blood
    22. BUNTINAS RL; LEWISTIBESAR K; POGATCHNIK DM; WIEMER DF; HOHL RJ
      ALTERATIONS OF RAS EXPRESSION IN HUMAN LEUKEMIA-CELLS INDUCED BY FARNESYL PYROPHOSPHATE ANALOGS

      Blood
    23. LEE CK; GINGRICH RD; HARMAN GS; HOHL RJ; SYSEL IA; FRANCY RJ; AJRAM KA; JOHANNSEN SM
      RISK FACTOR-DEPENDENT MODULATION OF GRAFT-VERSUS-HOST DISEASE (GVHD) BY GRADED INCREMENTAL T-CELL ADD-BACK (GIAB) IN T-CELL DEPLETION ALLOGENEIC BONE-MARROW TRANSPLANTATION (TCD-AL-BMT)

      Blood
    24. LEE CK; GINGRICH RD; HARMAN GS; HOHL RJ
      TBI-BVAC, AN EFFECTIVE ALLOGENEIC ABLATIVE REGIMEN FOR LYMPHOMA AND MULTIPLE-MYELOMA

      Blood
    25. LEE CK; GINGRICH RD; HOHL RJ; AJRAM KA
      ENGRAFTMENT SYNDROME IN AUTOLOGOUS BONE-MARROW AND PERIPHERAL STEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    26. CLAMON GH; RIGGS CE; DREICER R; HOHL RJ
      PHASE-II TRIAL OF EDATREXATE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER

      Investigational new drugs
    27. HOHL RJ; LEWIS K
      DIFFERENTIAL-EFFECTS OF MONOTERPENES AND LOVASTATIN ON RAS PROCESSING

      The Journal of biological chemistry
    28. HOHL RJ; LEWIS K
      PLASMA LOVASTATIN BIOACTIVITY AFTER HIGH-DOSE THERAPY FOR MALIGNANCY IN HUMANS

      Clinical pharmacology and therapeutics
    29. GINGRICH RD; LEE CK; WEN BC; HOHL RJ; HARMAN GS; AJRAM KA
      A PILOT-STUDY OF AUTOLOGOUS MARROW BLOOD STEM-CELL TRANSPLANTATION INTHE TREATMENT NONMETASTATIC INFLAMMATORY BREAST-CANCER/

      Blood
    30. LEE CK; GINGRICH RD; HARMAN GS; HOHL RJ; AIRAM KA; PADLEY DJ; HULING DA; TRIGG ME
      ANTI-CD3 (OKT3) T-CELL DEPLETION AND ADD-BACK (TCD-AB) - COMPARATIVE-ANALYSIS WITH ANTI-CD2 (CT2) TCD-AB IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    31. LEE CK; HARMAN GS; HOHL RJ; AJRAM KA; GINGRICH RD
      EFFECTS OF T-CELL DOSE AND GVHD ON IMMUNE RECONSTITUTION IN CD2 T-CELL DEPLETION AND 2-LEVEL ADD-BACK (TCD-AB) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    32. LEE CK; HAYASHI M; HARMAN GS; HOHL RJ; AJRAM KA; GINGRICH RD
      ANTI-CD2 T-CELL DEPLETION WITH 2-LEVEL T-CELL ADDBACK (TCD-AB) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (AL-BMT)

      Blood
    33. HOHL RJ; LEWISTIBESAR K
      TARGETING THE ISOPRENOID PATHWAY FOR ANTILEUKEMIA THERAPY IN HUMANS

      Blood
    34. SYSEL IA; LEE CK; FRANEY RJ; HARMAN GS; HOHL RJ; GINGRICH RD
      PULMONARY VENOOCCLUSIVE DISEASE (PVOD) IN THE ADULT BONE-MARROW TRANSPLANT POPULATION - 2 CASE-REPORTS

      Blood
    35. HOHL RJ; LEWIS K; CLAMON G; KNAPP H
      CLINICAL-PHARMACOLOGY OF HIGH-DOSE LOVASTATIN

      Clinical research
    36. HOHL RJ; LEWIS K; KNAPP HR
      PHARMACODYNAMIC EFFECTS OF IN-VIVO LOVASTATIN ON HUMAN LEUKEMIA-CELLS

      Clinical pharmacology and therapeutics
    37. GOLDMAN FD; HOHL RJ; CRABTREE J; KORETZKY G
      EFFECTS OF LOVASTATIN ON T-CELL SIGNALING

      Blood
    38. PETERS C; MILLER J; ABEL SL; MCMILLAN SK; GETCHEL JP; GILLER RH; HOHL RJ; DEALARCON PA
      IOWA NEWBORN HEMOGLOBINOPATHY (HBP) SCREENING AND COMPREHENSIVE CARE - A MODEL FOR RURAL

      Blood
    39. LEE CK; GINGRICH RD; HOHL RJ
      A DISTINCTIVE CLINICAL SYNDROME ACCOMPANYING THE ENGRAFTMENT PROCESS IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)

      Blood
    40. LEE CK; GINGRICH RD; HOHL RJ
      EFFECT OF STEROID FOR THE ENGRAFTMENT SYNDROME IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) ON SURVIVAL OF CHEMOSENSITIVE TUMORS AND IMMUNE RECONSTITUTION

      Blood
    41. HOHL RJ; LEWIS K; KNAPP HR
      BIOACTIVITY OF LOVASTATIN IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      Clinical research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 21:32:58